Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease

By News Health
4 weeks Ago

(MedPage Today) — ORLANDO — Infusions of the investigational monoclonal antibody veligrotug improved symptoms among patients with active and chronic thyroid eye disease, the phase III THRIVE clinical program showed.
By week 15 in 113 patients…

Source link : https://www.medpagetoday.com/meetingcoverage/aace/115658

Author :

Publish date : 2025-05-19 19:34:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

What Med Students Can Do If They See Unprofessional Behavior

Weight-Loss Drugs Show Promise but Remain Hard to Access

Symptom and Allergy Load Drives Food Allergy Distress

Most Chronic Hepatitis B Diagnoses in US Are Late

The Undervalued Medical Power of Muscle

AMA Calls for ACIP Answers, Stable Federal Funding